Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effects, Drug Side”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01271608
What this trial is testing

Study to Evaluate the Need of Needle Change for Application of Intramuscular, Subcutaneous and Intradermal Injection.

Who this might be right for
Knowledge, Attitudes, PracticeInjection Site Reactions
Hospital M'Boi Mirim 1,240
Testing effectiveness (Phase 2)Ended earlyNCT05022797
What this trial is testing

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Who this might be right for
Diffuse Large B-Cell LymphomaDrug Toxicity
Fundacion CRIS de Investigación para Vencer el Cáncer 3
Not applicableUnknownNCT04747678
What this trial is testing

Adverse Effects of Ivermectin Used in Egypt During COVID-19

Who this might be right for
Covid19Ivermectin PoisoningDrug Toxicity+1 more
Menoufia University 200
Not applicableStudy completedNCT02136017
What this trial is testing

Post-License Safety Evaluation of Influenza Virus Vaccine

Who this might be right for
InfluenzaAdverse Drug Event
Sichuan Center for Disease Control and Prevention 400,000
Not applicableUnknownNCT03938597
What this trial is testing

Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers

Who this might be right for
Drug-Related Side Effects and Adverse Reactions
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 10
Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Not applicableUnknownNCT05996276
What this trial is testing

Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION)

Who this might be right for
Esophagus Cancer
University Hospital, Brest 150
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Early research (Phase 1)Study completedNCT00003268
What this trial is testing

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Early research (Phase 1)UnknownNCT00024310
What this trial is testing

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003313
What this trial is testing

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerOral Complications+1 more
Radiation Therapy Oncology Group 243
Not applicableStudy completedNCT04116424
What this trial is testing

VIGIP-SEP2: Training of Patients by Nurses on ADR Reporting by RRMS Patient Via an App

Who this might be right for
Multiple Sclerosis
University Hospital, Caen 46
Post-approval studies (Phase 4)Study completedNCT02053974
What this trial is testing

Spironolactone Against Anthracycline-induced Cardiomyopathy

Who this might be right for
Anthracycline Induced Cardiotoxicity
TC Erciyes University 90
Early research (Phase 1)Study completedNCT04120233
What this trial is testing

MW151-101: First-in-human Study of MW151

Who this might be right for
Drug Toxicity
Linda Van Eldik 40
Not applicableUnknownNCT06048458
What this trial is testing

Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping

Who this might be right for
Cardiovascular DiseasesCardiotoxicityFluorouracil Adverse Reaction+5 more
University College, London 75
Not applicableStudy completedNCT07237906
What this trial is testing

Neutropenia With TNF-α Inhibitors

Who this might be right for
NeutropeniaTNF-alpha Inhibitors
Burak Ugur Cetin 122
Testing effectiveness (Phase 2)UnknownNCT03084952
What this trial is testing

Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

Who this might be right for
Leishmaniasis; American, CutaneousDrug Side Effect
Infan Industria Quimica Farmaceutica Nacional 52
Not applicableStudy completedNCT05939726
What this trial is testing

Efficacy and Safety of Moisturising Cream With or Without Vitamin E and Urea Cream in Palmar-plantar Erythrodysesthesia

Who this might be right for
Palmar-Plantar ErythrodysesthesiaPalmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy
Sarawak General Hospital 145
Not applicableStudy completedNCT02945176
What this trial is testing

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Who this might be right for
Graft vs Host DiseaseCongenital AniridiaChemical Burns+2 more
Implandata Ophthalmic Products GmbH 13
Post-approval studies (Phase 4)Study completedNCT01467050
What this trial is testing

Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients

Who this might be right for
Adverse Drug Reaction
University College Cork 732
Next Page